Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Ungaro UrsulaDirector
|
GrantClass A Common Stock | 23,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-014989 · marketforms-66801.xml · nonDerivative · entry 1 Ungaro Ursula · CIK 0001865511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Baluch KhosoDirector
|
GrantClass A Common Stock | 23,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-014990 · marketforms-66802.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,375 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001214659-24-014991 · marketforms-66803.xml · derivative · entry 2 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,500 Underlying: Class A Common Stock · 6,500 shares Expires 2034-08-15 F4 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2024. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
GrantClass A Common Stock | 93,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-014991 · marketforms-66803.xml · nonDerivative · entry 1 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 727,046 F1 · shares: Represents two time-based vesting Restricted Stock Unit (RSU) awards. F2 · balance_after: Amount includes 462,807 shares of Class B common stock, which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B common stock have identical rights to holders of common stock, except that holders of Class B common stock are entitled to 5 votes for each share held of record. Each share of Class B common stock is convertible at any time, at the option of the holder, into one share of common stock. F3 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Agafonova NataliyaChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 16,250 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001214659-24-014995 · marketforms-66807.xml · derivative · entry 3 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,250 Underlying: Class A Common Stock · 16,250 shares Expires 2034-08-15 F4 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2024. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Agafonova NataliyaChief Medical Officer
|
Tax withholdingClass A Common Stock | 14,391 | $2.46 | $35,401.86 |
DisclosureSEC source: 0001214659-24-014995 · marketforms-66807.xml · nonDerivative · entry 2 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,130 F2 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of an RSU award. F3 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Agafonova NataliyaChief Medical Officer
|
GrantClass A Common Stock | 175,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-014995 · marketforms-66807.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,521 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Locklear LisaChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,250 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001214659-24-014994 · marketforms-66806.xml · derivative · entry 3 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,250 Underlying: Class A Common Stock · 16,250 shares Expires 2034-08-15 F4 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2024. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Locklear LisaChief Financial Officer
|
Tax withholdingClass A Common Stock | 14,035 | $2.46 | $34,526.10 |
DisclosureSEC source: 0001214659-24-014994 · marketforms-66806.xml · nonDerivative · entry 2 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,631 F2 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of an RSU award. F3 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Locklear LisaChief Financial Officer
|
GrantClass A Common Stock | 174,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-014994 · marketforms-66806.xml · nonDerivative · entry 1 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,666 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Hashad Mohamed Wa'el AhmedChief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 28,750 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001214659-24-014993 · marketforms-66805.xml · derivative · entry 3 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,750 Underlying: Class A Common Stock · 28,750 shares Expires 2034-08-15 F4 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2024. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Hashad Mohamed Wa'el AhmedChief Executive Officer
|
Tax withholdingClass A Common Stock | 39,248 | $2.46 | $96,550.08 |
DisclosureSEC source: 0001214659-24-014993 · marketforms-66805.xml · nonDerivative · entry 2 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,368 F3 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Hashad Mohamed Wa'el AhmedChief Executive Officer
|
GrantClass A Common Stock | 311,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-014993 · marketforms-66805.xml · nonDerivative · entry 1 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,866 F1 · shares: Represents time-based vesting Restricted Stock Unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
GrantStock Option (right to buy) · Derivative | 16,250 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001214659-24-014992 · marketforms-66804.xml · derivative · entry 3 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,250 Underlying: Class A Common Stock · 16,250 shares Expires 2034-08-15 F4 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2024. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
Tax withholdingClass A Common Stock | 31,505 | $2.46 | $77,502.30 |
DisclosureSEC source: 0001214659-24-014992 · marketforms-66804.xml · nonDerivative · entry 2 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,709 F3 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of an RSU award. F2 · balance_after: Includes RSU subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
GrantClass A Common Stock | 178,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-014992 · marketforms-66804.xml · nonDerivative · entry 1 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,214 F1 · shares: Represents a time-based vesting Restricted Stock Unit (RSU) award. F2 · balance_after: Includes RSU subject to future vesting. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Soffer RockDirector
|
GrantClass A Common Stock | 23,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-014988 · marketforms-66800.xml · nonDerivative · entry 1 Soffer Rock · CIK 0001845308 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,034 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. F3 · balance_after: Share amounts include 41,050 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:30 UTC |
Hare Neil EDirector
|
GrantClass A Common Stock | 23,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-014987 · marketforms-66799.xml · nonDerivative · entry 1 Hare Neil E · CIK 0001845271 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,352 F1 · shares: Represents the award of time-based vesting Restricted Stock Unit (RSU). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 02, 2024 Filed Aug 7, 2024 22:00 UTC |
Hajjar Roger JosephDirector
|
GrantClass A Common Stock | 16,000 | $1.68 | $26,880.00 |
DisclosureSEC source: 0001214659-24-014048 · marketforms-66733.xml · nonDerivative · entry 1 Hajjar Roger Joseph · CIK 0002032469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 F1 · shares: Grant of restricted stock units granted upon joining the Board of Directors, which vest quarterly in equal installments over a period of three years, issued under the Second Amended and Restated Longeveron Inc. 2021 Equity Incentive Plan. Read SEC document |
| July 02, 2024 Filed Aug 7, 2024 18:00 UTC |
Motwani Neha J.Director
|
GrantClass A Common Stock | 16,000 | $1.68 | $26,880.00 |
DisclosureSEC source: 0001214659-24-014047 · marketforms-66732.xml · nonDerivative · entry 1 Motwani Neha J. · CIK 0002031045 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 F1 · shares: Grant of restricted stock units granted upon joining the Board of Directors, which vest quarterly in equal installments over a period of three years, issued under the Second Amended and Restated Longeveron Inc. 2021 Equity Incentive Plan. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 23:00 UTC |
Locklear LisaChief Financial Officer
|
Tax withholdingClass A Common Stock | 357 | $1.57 | $560.49 |
DisclosureSEC source: 0001214659-24-011986 · marketforms-66508.xml · nonDerivative · entry 1 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,916 Read SEC document |
| June 09, 2024 Filed Jun 11, 2024 21:00 UTC |
Baluch KhosoDirector
|
Tax withholdingCommon Stock | 125 | $1.06 | $132.50 |
DisclosureSEC source: 0001214659-24-010840 · marketforms-66330.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,875 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| June 03, 2024 Filed Jun 7, 2024 22:00 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
Tax withholdingClass A Common Stock | 325 | $1.04 | $338.00 |
DisclosureSEC source: 0001214659-24-010719 · marketforms-66266.xml · nonDerivative · entry 1 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,081 F1 · shares: Includes Restricted Stock Units subject to future vesting. F2 · balance_after: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| May 10, 2024 Filed May 14, 2024 19:10 UTC |
Kender Richard NDirector
|
GrantClass A Common Stock | 16,000 | $1.46 | $23,280.00 |
DisclosureSEC source: 0001214659-24-009103 · marketforms-65873.xml · nonDerivative · entry 1 Kender Richard N · CIK 0001381205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 F1 · shares: Grant of restricted stock units, which vest quarterly in equal installments over a period of three years, under the Company's Equity Incentive Plan. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:59 UTC |
Locklear LisaChief Financial Officer
|
Tax withholdingClass A Common Stock | 410 | $2.83 | $1,160.30 |
DisclosureSEC source: 0001214659-24-008445 · marketforms-65772.xml · nonDerivative · entry 1 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,273 F1 · balance_after: Amounts reflect the one-for-ten reverse stock split undertaken by Issuer in April 2024. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:59 UTC |
Agafonova NataliyaChief Medical Officer
|
Tax withholdingClass A Common Stock | 308 | $2.83 | $871.64 |
DisclosureSEC source: 0001214659-24-008444 · marketforms-65770.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,771 F1 · balance_after: Amounts reflect the one-for-ten reverse stock split undertaken by Issuer in April 2024. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 23:00 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
PurchaseWarrant (right to buy) · Derivative | 42,553 | $0.13 Strike: $2.35 | $5,319.13 |
DisclosureSEC source: 0001214659-24-006773 · marketforms-65541.xml · derivative · entry 4 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,553 Underlying: Class A Common Stock · 42,553 shares Expires 2029-04-10 Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 23:00 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
PurchaseClass A Common Stock | 42,553 | $2.35 | $99,999.55 |
DisclosureSEC source: 0001214659-24-006773 · marketforms-65541.xml · nonDerivative · entry 2 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 633,280 F2 · balance_after: Amount includes 462,807 shares of Class B common stock, which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B common stock have identical rights to holders of common stock, except that holders of Class B common stock are entitled to 5 votes for each share held of record. Each share of Class B common stock is convertible at any time, at the option of the holder, into one share of common stock. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 23:00 UTC |
Hashad Mohamed Wa'el AhmedDirector · Chief Executive Officer
|
PurchaseWarrant (right to buy) · Derivative | 10,638 | $0.13 Strike: $2.35 | $1,329.75 |
DisclosureSEC source: 0001214659-24-006772 · marketforms-65539.xml · derivative · entry 2 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,638 Underlying: Class A Common Stock · 10,638 shares Expires 2029-04-10 Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 23:00 UTC |
Hashad Mohamed Wa'el AhmedDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 10,638 | $2.35 | $24,999.30 |
DisclosureSEC source: 0001214659-24-006772 · marketforms-65539.xml · nonDerivative · entry 1 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,616 Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 23:00 UTC |
Soffer RockDirector
|
PurchaseWarrant (right to buy) · Derivative | 31,915 | $0.13 Strike: $2.35 | $3,989.38 |
DisclosureSEC source: 0001214659-24-006771 · marketforms-65540.xml · derivative · entry 4 Soffer Rock · CIK 0001845308 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,915 Underlying: Class A Common Stock · 31,915 shares Expires 2029-04-10 Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 23:00 UTC |
Soffer RockDirector
|
PurchaseClass A Common Stock | 31,915 | $2.35 | $75,000.25 |
DisclosureSEC source: 0001214659-24-006771 · marketforms-65540.xml · nonDerivative · entry 2 Soffer Rock · CIK 0001845308 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,534 Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 23:00 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
PurchaseWarrant (right to buy) · Derivative | 106,383 | $0.13 Strike: $2.35 | $13,297.88 |
DisclosureSEC source: 0001214659-24-006773 · marketforms-65541.xml · derivative · entry 3 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,383 Underlying: Class A Common Stock · 106,383 shares Expires 2029-04-10 Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 23:00 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
PurchaseClass A Common Stock | 106,383 | $2.35 | $250,000.05 |
DisclosureSEC source: 0001214659-24-006773 · marketforms-65541.xml · nonDerivative · entry 1 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 590,727 F1 · balance_after: Since the date of the reporting person's last ownership report on Table I, he transferred 298,483 shares of Class B common stock to his ex-spouse pursuant to a domestic relations order. The reporting person retains voting, but not dispositive or economic rights, with respect to the shares, pursuant to the terms of a Voting Agreement. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 23:00 UTC |
Soffer RockDirector
|
PurchaseWarrant (right to buy) · Derivative | 106,383 | $0.13 Strike: $2.35 | $13,297.88 |
DisclosureSEC source: 0001214659-24-006771 · marketforms-65540.xml · derivative · entry 3 Soffer Rock · CIK 0001845308 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,383 Underlying: Class A Common Stock · 106,383 shares Expires 2029-04-10 Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 23:00 UTC |
Soffer RockDirector
|
PurchaseClass A Common Stock | 106,383 | $2.35 | $250,000.05 |
DisclosureSEC source: 0001214659-24-006771 · marketforms-65540.xml · nonDerivative · entry 1 Soffer Rock · CIK 0001845308 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,619 F1 · balance_after: Share amounts include 64,010 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. Read SEC document |
| March 12, 2024 Filed Mar 20, 2024 21:00 UTC |
Hashad Mohamed Wa'el AhmedDirector · Chief Executive Officer
|
Tax withholdingCommon Stock, par value $0.001 per share | 32,866 | $0.54 | $17,747.64 |
DisclosureSEC source: 0001214659-24-004897 · marketforms-65301.xml · nonDerivative · entry 2 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,777 Read SEC document |
| March 12, 2024 Filed Mar 20, 2024 21:00 UTC |
Hashad Mohamed Wa'el AhmedDirector · Chief Executive Officer
|
GrantCommon Stock, par value $0.001 per share | 80,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-004897 · marketforms-65301.xml · nonDerivative · entry 1 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,643 F1 · shares: Amount consists of payment of performance shares upon certification of performance by the Compensation Committee of Longeveron Inc. Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 23:00 UTC |
Ross CathyDirector
|
PurchaseCommon Stock | 5,000 | $1.31 | $6,544.50 |
DisclosureSEC source: 0001214659-24-000652 · marketforms-64297.xml · nonDerivative · entry 1 Ross Cathy · CIK 0001845222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price per share reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.31, inclusive. The reporting person undertakes to provide to Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in herein. Read SEC document |
| January 02, 2024 Filed Jan 25, 2024 23:00 UTC |
Locklear LisaChief Financial Officer
|
Tax withholdingCommon Stock | 4,098 | $1.32 | $5,409.36 |
DisclosureSEC source: 0001214659-24-001204 · marketforms-64497.xml · nonDerivative · entry 1 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,824 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| January 02, 2024 Filed Jan 25, 2024 23:00 UTC |
Hashad Mohamed Wa'el AhmedDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 5,123 | $1.32 | $6,762.36 |
DisclosureSEC source: 0001214659-24-001203 · marketforms-64495.xml · nonDerivative · entry 1 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,443 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| January 02, 2024 Filed Jan 25, 2024 23:00 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
Tax withholdingCommon Stock | 992 | $1.32 | $1,309.44 |
DisclosureSEC source: 0001214659-24-001201 · marketforms-64494.xml · nonDerivative · entry 1 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,406 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| January 02, 2024 Filed Jan 25, 2024 23:00 UTC |
Agafonova NataliyaChief Medical Officer
|
Tax withholdingCommon Stock | 3,074 | $1.32 | $4,057.68 |
DisclosureSEC source: 0001214659-24-001202 · marketforms-64496.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,786 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 23:00 UTC |
Baluch KhosoDirector
|
PurchaseCommon Stock | 8,322 | $1.43 | $11,914.61 |
DisclosureSEC source: 0001214659-24-000079 · marketforms-63954.xml · nonDerivative · entry 2 Baluch Khoso · CIK 0001686223 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · price: The price per share reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.39 to $1.45, inclusive. The reporting person undertakes to provide to Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 17:00 UTC |
PFEFFER JEFFREYDirector
|
PurchaseCommon Stock | 10,000 | $1.35 | $13,500.00 |
DisclosureSEC source: 0001214659-23-017126 · marketforms-63950.xml · nonDerivative · entry 1 PFEFFER JEFFREY · CIK 0001180836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| December 28, 2023 Filed Jan 2, 2024 23:00 UTC |
Baluch KhosoDirector
|
PurchaseCommon Stock | 1,678 | $1.40 | $2,341.98 |
DisclosureSEC source: 0001214659-24-000079 · marketforms-63954.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,678 Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 18:00 UTC |
PFEFFER JEFFREYDirector
|
GrantStock Option (Right to buy) · Derivative | 12,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001214659-23-016871 · marketforms-63912.xml · derivative · entry 1 PFEFFER JEFFREY · CIK 0001180836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2033-12-21 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 23:00 UTC |
Ungaro UrsulaDirector
|
GrantStock Option (Right to buy) · Derivative | 12,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001214659-23-016874 · marketforms-63914.xml · derivative · entry 1 Ungaro Ursula · CIK 0001865511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2033-12-21 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 23:00 UTC |
Baluch KhosoDirector
|
GrantStock Option (Right to buy) · Derivative | 12,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001214659-23-016872 · marketforms-63913.xml · derivative · entry 1 Baluch Khoso · CIK 0001686223 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2033-12-21 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant. Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 23:00 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
GrantStock Option (Right to buy) · Derivative | 12,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001214659-23-016876 · marketforms-63918.xml · derivative · entry 1 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2033-12-21 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.